S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain
NCT03003845 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21
Last updated 2021-07-23
Summary
For each patient in the study, blood, and pain scores will be collected to look for markers for pain, at the start of treatment and 6 months after surgery of treatment.
Conditions
- Interstitial Cystitis
Interventions
- OTHER
-
Questionnaires
QOL and pain questionnaires will be given to patients at 3, 6, and 12 months post surgery
- OTHER
-
Collection of Blood samples
Blood for PBLs will be collected at 3, 6, and 12 months post surgery
Sponsors & Collaborators
-
St. Louis University
lead OTHER
Principal Investigators
-
Eugen C Campian, MD · St. Louis University
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-02-26
- Primary Completion
- 2020-02-27
- Completion
- 2020-02-27
Countries
- United States
Study Locations
More Related Trials
-
A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome
NCT02868775 ·Status: UNKNOWN
-
Interstitial Cystitis: Examination of the Central Autonomic Network
NCT03008382 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (Pilot Study)
NCT02331472 ·Status: COMPLETED
-
Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis
NCT05912946 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms
NCT05276466 ·Status: UNKNOWN ·Phase: NA
-
Clinical Features and Histologic Findings in Bladder Pain Syndrome/Interstitial Cystitis
NCT03069053 ·Status: COMPLETED
-
A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis
NCT02787083 ·Status: TERMINATED ·Phase: PHASE3
-
PK and Safety of SI-722 in IC/BPS
NCT04208087 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Interstitial Cystitis (IC)-Like Findings With Hydrodistension
NCT02547298 ·Status: TERMINATED
-
Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action
NCT01990898 ·Status: COMPLETED ·Phase: PHASE2
-
Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)
NCT00704457 ·Status: COMPLETED
-
Efficacy and Safety of AQX-1125 in IC/BPS
NCT01882543 ·Status: COMPLETED ·Phase: PHASE2
-
Emotional Urinary Tract Infection
NCT07191041 ·Status: NOT_YET_RECRUITING
-
Trial Comparing Outpatient Flexible to Rigid Cystoscopy in Females
NCT00945594 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome
NCT01985880 ·Status: COMPLETED
-
A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
NCT05740007 ·Status: TERMINATED ·Phase: PHASE2
-
Vulvodynia: Identification of Potential Relevant Biomarkers
NCT02981433 ·Status: COMPLETED
-
Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.
NCT00775281 ·Status: COMPLETED
-
Microbiome of Urologic Chronic Pelvic Pain Syndrome
NCT03027076 ·Status: WITHDRAWN
-
Platelet Activating Factor Stability in Urine
NCT03103477 ·Status: COMPLETED
-
Microbiomes of Pelvic Pain
NCT01738464 ·Status: COMPLETED
-
Supervised Exercise as a Therapeutic Strategy for Interstitial Cystitis/Bladder Pain Syndrome
NCT05699551 ·Status: WITHDRAWN ·Phase: NA
-
Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
NCT00517868 ·Status: TERMINATED ·Phase: PHASE2
-
Correlating Ic/Pbs Symptoms With Urine Biomarkers
NCT00817388 ·Status: COMPLETED
-
Diagnosis of Bladder Pain Syndrome / Interstitial Cystitis
NCT03023241 ·Status: COMPLETED ·Phase: NA